Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Apellis Pharmaceuticals, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 263 | 3 | 265 | +5 |
| Shares | 115.4M | 5.80M | 118.2M | +8.54M (+7.8%) |
| Value | $4.43B | $222.3M | $3.41B | −$795.7M (−18.9%) |
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (44)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (39)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (3)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 5,795,272 | $222.3M |
| Sofos Investments, Inc. | 100 | $3.84K |
| Benjamin F. Edwards & Company, Inc. | 15 | $1.00K |